The 30s · 40s · 50s: What Actually Changes in Lifting Treatment

Phrases like “lifting for your 40s” and “lifting for your 50s” are familiar. But once you look at which age groups the actual studies compared, the story changes.

In other words, we could not find a study that directly tested the proposition that “lifting should differ by decade” in ten-year blocks. The same applies to the widely used scheme of “sagging in your 40s, volume loss in your 50s.” What the fat compartment study actually compared was people over 54 versus people over 75.

That does not mean the three decades are the same. It means the evidence supporting the difference lies elsewhere.

Let us take the 30s first. There is less that we can honestly say about this decade than you might expect.

That dermal change has already begun in the 30s is confirmed. In a study measuring the ratio of elastic fibers to collagen in skin with in vivo multiphoton microscopy, comparing a group with a mean age of 28 against a group with a mean age of 54 gave the following.

There are two things to read here. One is that the change is greater in the deep dermis; the other is that there is no point at which it suddenly turns at a particular age. The 2024 autopsy tissue study says the same thing — the authors wrote that “aging is gradual and does not show distinct decade-based thresholds.”

But there is a gap here. People in their 30s are almost absent from the lifting research. The studies included in the 16-paper systematic review of ultrasound lifting had a mean age of about 44 to 52, and the mean age in the radiofrequency response prediction study (25 subjects) was 52.3. Neither the 42-paper meta-analysis nor the 45-paper systematic review contains any age subgroup analysis.

So what we can say about the 30s is this. It is true that change is beginning inside the skin. But there is effectively no clinical data supporting “you should have lifting devices in your 30s.” If what bothers you in your 30s is mainly texture · pores · density, that is the territory of skin boosters, not of lifting devices. There is no reason to use a device that addresses sagging when the sagging has not arrived yet.

Among the events that sit between the 40s and the 50s, there is one whose timing is confirmed by large-scale Korean data.

This is the only axis dividing the 40s from the 50s that is backed by large-scale Korean data. It is far more solid than claims that bone or fat differ by decade.

That is why, at Miso Clinic, we ask “are you before or after menopause?” before we ask “how old are you?” Forty-nine and fifty-one are two years apart as numbers, but they can sit in different places on this axis; conversely, some patients are fifty-five and still before the transition. We look at the individual’s point in time, not the decade.

Here is something we should write down honestly. The sentence “30% of skin collagen is lost within five years of menopause” is everywhere. We went looking for the primary source of that figure.

• The studies pointed to as the source are a series of small studies published between 1983 and 1987 by one London research group (Brincat, Studd and colleagues).
• But a peer-reviewed review (2024) citing the 1987 paper gives the figure as “a 45% decrease at 15 years post-menopause” — a different interval and a different percentage from the widely circulated “30% in five years.”
• Different citing sources point to different papers, and we could not verify the sample sizes and measurement methods of those original papers directly.
• The measurements of that era are understood to have been made on skin biopsies taken from sites other than the face.

So we do not use that number in this article. Written up only as far as we verified it, it comes to this — the observation that skin collagen declines after menopause has been reported for forty years, and multiple studies support the idea that estrogen is involved in dermal collagen and skin thickness. But the precise rate and magnitude of that decline has never been re-measured on the face with modern methods.

A 2024 review of menopausal skin acknowledges the same gap. That review states that “there is currently no approved effective treatment to prevent or alleviate the skin changes associated with estrogen deficiency.”

This may sound like bad news, but it is actually the opposite. If the exact rate of decline has not been verified, then there is also no basis for using that number to say “if you don’t act now it will be too late.” As you will see below, the actual data are far more optimistic than that.

That the facial skeleton changes with age has been confirmed by CT. In a study measuring 120 Caucasian subjects with three-dimensional CT, researchers observed that the width and area of the orbit increase, while mandibular length and height decrease and the mandibular angle widens. The report that the maxilla retrudes also comes from here.

But a CT study in Korean subjects produced a different result.

In other words, the explanation that “the maxilla retrudes with age, so that space must be filled” was not reproduced as such in data from Korean women. The one change that was confirmed is that the anterior cheek becomes more concave.

This result is genuinely good news. It means that instead of recommending broad skeletal augmentation on the basis of Western data, we can design a narrower scope matched to the changes actually observed in Korean subjects.

This is the most important material in this article. There is a study that followed 25 people who received monopolar radiofrequency lifting at 3 months · 6 months · 12 months and analyzed which factors predicted treatment response. The mean age of the participants was 52.3 years.

To summarize: the less lax the tissue, the better the response, and age was not nearly as decisive.

Between a fifty-five-year-old with firm skin and a forty-two-year-old who is already quite lax, the one this study predicts will respond better is the former. This is exactly what we see in the consulting room as well. That is why we do not tell patients “at your age you should have this done.”

To add to this: a meta-analysis pooling 42 ultrasound lifting papers (2025), a 45-paper systematic review (2025) and a 475-patient meta-analysis (2025) contain no age subgroup analysis anywhere. Published comparative data supporting “it works well in the 40s but differently in the 50s” currently do not exist.

This question comes up often in consultations with patients in their 40s: if I start managing it now, will I sag less later? We went looking for evidence too.

The most concrete material was a computer modeling study simulating 15 years of botulinum toxin treatment (2026). Three cohorts starting in their 20s · 30s · 40s were simulated at two sessions per year and three sessions per year.

• Over the first five years, wrinkle reduction was greatest in those who started early and were treated more often.
• But by year 15 the wrinkle depth of all cohorts converged to similar values, and the structural aging measures were effectively indistinguishable across treatment intervals.

The researchers themselves state that “these results must be validated by long-term prospective studies in multiethnic human subjects.” No study has yet confirmed this in people.

That is why we do not tell patients “if you don’t start now it will be too late later.” We could not find human evidence supporting that statement. A procedure is something you do when something bothers you now, not something you take out against a future that has not arrived. This view removes the reason to hurry for those in their 30s and 40s, and erases the premise of ‘it is already too late’ for those in their 50s.

Once the evidence is organized, the practical differences that remain are as follows. This is a division based on the conditions commonly observed in each decade, not on age itself.

The actual decision is made like this.

1. We look at the degree of laxity first. On the evidence, it is the only factor that predicted response. If there is no sagging yet, we do not recommend lifting devices.
2. We look at thickness and fat volume and then set depth · tip · power. This part is written up separately in Lifting treatment should vary with skin thickness and fat volume.
3. Depending on whether the main problem is density and texture, sagging, or volume loss, we divide the weighting between skin boosters and lifting. That distinction is set out in Booster or lifting — which comes first.
4. When laxity is advanced, we say in advance how far a device can go. The numbers in the next section are that benchmark.

Regardless of decade, it is better to begin knowing the magnitude of change that has actually been measured with non-surgical lifting. A systematic review pooling 16 papers has compiled the objectively measured amount of lift.

Measured lift is 0.5 to 1.7mm, while the investigator-assessed improvement rate is 92%. We think it is better not to hide that gap. Non-surgical lifting produces change on the order of millimeters, and that change reads as a ‘tidier impression’ in photographs and in the mirror. It is not a procedure that changes your face.

The systematic review concludes that correcting severe laxity and achieving genuine long-term tightening require surgical management, and the same literature also states explicitly that the patient selection criteria separating non-surgical from surgical candidates have not yet been defined in the literature. So we make that judgment by looking directly, with photographs and palpation, and tell you what we see.

• Verified — the average age of natural menopause in Korean women is about 49 to 50 (surveys of 1,941 · 2,807 women). This is the most solid axis dividing the 40s from the 50s.
• Verified — in Korean CT data (114 subjects), maxillary retrusion was not significant in women, and only the increasing concavity of the anterior cheek was confirmed.
• Verified — what predicted response to radiofrequency lifting was not age but how lax the tissue was (25 subjects, 12 months).
• Could not verify — the primary source of “a 30% collagen loss in the five years after menopause.” Citing sources contradict one another and we could not verify the original papers.
• Where the evidence is thin — the 30s. Dermal change has already begun, but because the mean age in lifting clinical studies is 44 to 52, this decade has effectively not been studied.
• No evidence — a study comparing lifting response between decades, and a study showing in humans that “treating early means less sagging later.” We could not find either.

So the conclusion of this article is not “a procedure suited to your decade” but “a procedure suited to your current condition.” For those in their 30s that means there is no reason to address a problem that has not arrived yet, for those in their 40s it means there is no reason to rush, and for those in their 50s it means it is not too late. That is the direction the evidence points.

Written and reviewed by Lee Chi-Hak, MD, medical director of Miso Clinic in Daegu, South Korea. Every study cited above is given together with its design, its size and the limitations the authors themselves recorded, and where we could not find data, we have said that we could not find any.